OTC Medicines

Browse OTC Medicines Content

As a direct result of the PROTECT initiative, CHPA developed a voluntary guideline for industry suggesting ways to standardize volumetric measures in dosing directions and dosing devices for oral pediatric liquid drug products.

Learn about the process of transferring FDA-approved prescription medications to nonprescription, over-the-counter status.

CHPA and its members, the U.S. manufacturers and distributors of OTC medicines and nutritional supplements, recognize the efforts of the FDA to further develop methodologies and techniques for characterization of nanomaterials for drug applications.

Learn about the OTC review process, drug monographs, and time and extent applications.

CHPA is committed to advancing solutions to illegal sales that penalize criminals and ensure law-abiding consumers continue to have access to a wide range of treatment options, including nonprescription medicines containing PSE.

CHPA is uniquely positioned to provide access to OTC medicines and dietary supplements in nearly every category that can be donated and customized to the needs of underserved communities. Our product donation initiative is an ongoing effort to support these communities. So far, CHPA member companies have donated 70,000 products to people in need.

Current good manufacturing practices establish uniform standards to ensure quality throughout the manufacturing, packaging, labeling, and holding of OTC medicines and dietary supplement products.

CHPA opposes mandatory manufacturer-funded drug take-back programs as they threaten the affordability of OTC medications that consumers rely on as the first line of defense against common ailments.

Filter Results